Publications found:
36,694
Sort by:
Neurofibroma - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurofibroma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Neurofibromatosis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurofibromatosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Neurofibromatosis Type 2 - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurofibromatosis Type 2 - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Neurofibrosarcoma - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurofibrosarcoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Neuromyelitis Optica - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neuromyelitis Optica - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Neurotrophic Keratitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurotrophic Keratitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Neurotrophic keratopathy - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Neurotrophic keratopathy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
NGLY1 Deficiency - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'NGLY1 Deficiency - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Niemann Pick Disease - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Niemann Pick Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Night Vision Disturbances - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Night Vision Disturbances - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Nitric oxide synthase inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Nitric oxide synthase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and...
January 2022
60 pages
NK Cell therapies - Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 90 hours DelveInsight’s, “NK Cell therapy - Pipeline Insight, 2022” report provides comprehensive insights about 80+ companies and 100+ pipeline dr...
January 2022
120 pages
NLRP3 protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “NLRP3 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies an...
January 2022
60 pages
NMDA receptor antagonists - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “NMDA Receptor Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pi...
January 2022
120 pages
Nociceptin receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Nociceptin receptor agonists - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companie...
January 2022
60 pages
Nonmelanoma Skin Cancer- Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Nonmelanoma Skin Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Noonan Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Noonan Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Notch receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Notch receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pip...
January 2022
60 pages
